Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure.
Saved in:
| Title: | Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure. |
|---|---|
| Authors: | Tomelleri, Alessandro1,2, Bond, Milena3, Marvisi, Chiara4, Campochiaro, Corrado1,2, Farina, Nicola1,2, Venerandi, Biancamaria1,2, Matucci-Cerinic, Marco1,2, Salvarani, Carlo4, Dejaco, Christian3,5, Dagna, Lorenzo1,2 |
| Source: | Rheumatology. Sep2025, Vol. 64 Issue 9, p5118-5122. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!